These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24398404)

  • 1. The vesicular monoamine transporter 2: an underexplored pharmacological target.
    Bernstein AI; Stout KA; Miller GW
    Neurochem Int; 2014 Jul; 73():89-97. PubMed ID: 24398404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport.
    Bernstein AI; Stout KA; Miller GW
    J Neurosci Methods; 2012 Aug; 209(2):357-66. PubMed ID: 22698664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2.
    Finn JP; Edwards RH
    J Biol Chem; 1997 Jun; 272(26):16301-7. PubMed ID: 9195934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine.
    Lawal HO; Krantz DE
    Mol Aspects Med; 2013; 34(2-3):360-72. PubMed ID: 23506877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of two vesicular monoamine transporters.
    Peter D; Liu Y; Sternini C; de Giorgio R; Brecha N; Edwards RH
    J Neurosci; 1995 Sep; 15(9):6179-88. PubMed ID: 7666200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Involvement of vesicular monoamine transporter in attention deficit hyperactivity disorder].
    Lorenzo-Sanz G; Sánchez-Herranz A
    Rev Neurol; 2011 Mar; 52 Suppl 1():S103-8. PubMed ID: 21365590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain.
    Cliburn RA; Dunn AR; Stout KA; Hoffman CA; Lohr KM; Bernstein AI; Winokur EJ; Burkett J; Schmitz Y; Caudle WM; Miller GW
    J Chem Neuroanat; 2017 Oct; 83-84():82-90. PubMed ID: 27836486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular monoamine and glutamate transporters select distinct synaptic vesicle recycling pathways.
    Onoa B; Li H; Gagnon-Bartsch JA; Elias LA; Edwards RH
    J Neurosci; 2010 Jun; 30(23):7917-27. PubMed ID: 20534840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons.
    Guillot TS; Miller GW
    Mol Neurobiol; 2009 Apr; 39(2):149-70. PubMed ID: 19259829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.
    Temple W; Mendelsohn L; Kim GE; Nekritz E; Gustafson WC; Lin L; Giacomini K; Naranjo A; Van Ryn C; Yanik GA; Kreissman SG; Hogarty M; Matthay KK; DuBois SG
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):474-481. PubMed ID: 26338179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters.
    Mulvihill KG
    Neurochem Int; 2019 Jan; 122():94-105. PubMed ID: 30465801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport of histamine by vesicular monoamine transporter-2.
    Merickel A; Edwards RH
    Neuropharmacology; 1995 Nov; 34(11):1543-7. PubMed ID: 8606801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of neurotransmitter transport and drug inhibition in human VMAT2.
    Pidathala S; Liao S; Dai Y; Li X; Long C; Chang CL; Zhang Z; Lee CH
    Nature; 2023 Nov; 623(7989):1086-1092. PubMed ID: 37914936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors.
    Duerr JS; Frisby DL; Gaskin J; Duke A; Asermely K; Huddleston D; Eiden LE; Rand JB
    J Neurosci; 1999 Jan; 19(1):72-84. PubMed ID: 9870940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.
    Erickson JD; Schafer MK; Bonner TI; Eiden LE; Weihe E
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5166-71. PubMed ID: 8643547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the vesicular monoamine transporter 1 (vmat1/slc18a1) gene affects dopamine signaling.
    Lohoff FW; Carr GV; Brookshire B; Ferraro TN; Lucki I
    Brain Res; 2019 Jun; 1712():151-157. PubMed ID: 30685272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
    Schütz B; Schäfer MK; Eiden LE; Weihe E
    Brain Res Dev Brain Res; 1998 Mar; 106(1-2):181-204. PubMed ID: 9555003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first luminal domain of vesicular monoamine transporters mediates G-protein-dependent regulation of transmitter uptake.
    Brunk I; Blex C; Rachakonda S; Höltje M; Winter S; Pahner I; Walther DJ; Ahnert-Hilger G
    J Biol Chem; 2006 Nov; 281(44):33373-85. PubMed ID: 16926160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of a vesicular monoamine transporter by casein kinase II.
    Krantz DE; Peter D; Liu Y; Edwards RH
    J Biol Chem; 1997 Mar; 272(10):6752-9. PubMed ID: 9045708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.